Becton Dickinson: Michael Feld

Becton Dickinson：迈克尔·费尔德

Becton Dickinson has named Michael Feld as executive VP and president of the life sciences business, effective Aug. 20. Feld replaces Dave Hickey, who retired from BD in July. Feld most recently served as president of Danaher subsidiary Veralto's Hach water quality product business. Prior to that, he was senior VP and general manager of Cepheid Europe as well as president of other Danaher businesses, including Mammotome, XOS, and Dover Motion..

BectonDickinson已任命Michael Feld为生命科学业务执行副总裁兼总裁，自8月20日起生效。费尔德接替戴夫·希基，后者于7月从BD退休。费尔德（Feld）最近担任达纳赫（Danaher）子公司维拉托（Veralto）的哈奇（Hach）水质产品业务总裁。在此之前，他曾担任造父变星欧洲公司的高级副总裁兼总经理，以及其他Danaher公司的总裁，包括Mammotome、XOS和Dover Motion。。

Biocartis: Michael Korn

生物艺术：迈克尔·科恩

Biocartis appointed Michael Korn as its chief medical and scientific officer, effective Aug. 12. Korn previously served as chief medical officer at Invitae and as CMO at Caris Life Sciences. He is currently a volunteer faculty member at the University of California San Francisco and cofounded the Center for Molecular Oncology Initiative at the UCSF Helen Diller Family Comprehensive Cancer Center..

Biocartis任命迈克尔·科恩为首席医学和科学官，自8月12日起生效。Korn曾担任Invitae的首席医疗官和Caris Life Sciences的首席医学官。他目前是加州大学旧金山分校的志愿者，并在加州大学旧金山分校海伦·迪勒家庭综合癌症中心共同创立了分子肿瘤学中心。。

Seer: Nicolas Roelofs

年份：尼古拉斯·罗洛夫

Nicolas Roelofs has been appointed to the board of directors of proteomics firm Seer. He is the chairman of Sengenics, a board member of Velsera, and an advisory board member of 908 Devices. Previously, he was president of the life sciences group at Agilent Technologies, group operations officer for the life sciences division at Bio-Rad Laboratories, and chief operating officer at Stratagene.

尼古拉斯·罗洛夫斯被任命为蛋白质组学公司Seer的董事会成员。他是Sengenics的董事长，Velsera的董事会成员，以及908个设备的顾问委员会成员。此前，他曾任安捷伦科技公司生命科学集团总裁、Bio-Rad实验室生命科学部集团运营官和Stratagene首席运营官。

Roelofs holds a PhD in organic chemistry from the University of Nevada, a master's degree in organic chemistry from Iowa State University, and a bachelor's degree in chemistry, biology, and German from Simpson College..

Roelofs拥有内华达大学有机化学博士学位，爱荷华州立大学有机化学硕士学位，辛普森学院化学、生物学和德语学士学位。。

Ultima Genomics: Chris Seipert, Lara Toerien

《创世纪基因组学》：克里斯·塞珀特、劳拉·托里恩

Ultima Genomics has appointed Chris Seipert as VP of operations and Lara Toerien as VP of sales for North America.

Ultima Genomics已任命Chris Seipert为运营副总裁，Lara Toerien为北美销售副总裁。

Seipert joins the firm after spending 14 years at Pacific Biosciences, most recently as VP of global operations. Before that, he was PacBio's VP of customer experience, VP and general manager of the Americas and EMEA, VP of global service and support, and VP of instrument manufacturing and field service engineering.

Seipert在太平洋生物科学公司（Pacific Biosciences）工作了14年后加入该公司，最近一次担任全球运营副总裁。在此之前，他曾任PacBio的客户体验副总裁、美洲和欧洲、中东和非洲副总裁兼总经理、全球服务和支持副总裁、仪器制造和现场服务工程副总裁。

Prior to joining PacBio, he held engineering roles at KLA-Tencor. Seipert has an MS in engineering and a BS in physics from San Jose State University..

在加入PacBio之前，他曾在KLA Tencor担任工程师。Seipert拥有圣何塞州立大学的工程学硕士和物理学学士学位。。

Toerien also comes to Ultima from PacBio, where she was VP and general manager for the Americas. Previously, she spent 16 years at Illumina, holding roles in the sales organization in North America. Before that, she spent seven years working in sales at Invitrogen. Toerien holds a BS in molecular and cell biology from Penn State University and a PhD in molecular biology from the University of California, San Diego..

Toerien还从PacBio来到Ultima，她曾任PacBio副总裁兼美洲区总经理。此前，她在Illumina工作了16年，在北美的销售组织中担任职务。。Toerien拥有宾夕法尼亚州立大学分子与细胞生物学学士学位和加利福尼亚大学圣地亚哥分校分子生物学博士学位。。

OpGen: Christian-Laurent Bonte, Victor Chua, Ken Lim, Ethan Low, Constance Wong

OpGen：克里斯蒂安·劳伦特·邦特（Christian Laurent Bonte）、维克托·蔡（Victor Chua）、肯·林（Ken Lim）、伊桑·洛（Ethan Low）、康斯坦斯·王（Constance Wong）

OpGen has appointed Christian-Laurent Bonte, Victor Chua, Ken Lim, Ethan Low, and Constance Wong as directors of the company. The initial term for each of the directors will expire at the company's 2024 annual meeting of stockholders.

。每位董事的初始任期将在公司2024年股东年会上到期。

Bonte is the founder of Far Cap, a Singapore-based corporate financing and investing business, while Chua is founder of venture capital firm Vynn Capital, and Lim is CEO and executive director of the European Credit Investment Bank.

Bonte是总部位于新加坡的企业融资和投资业务Far Cap的创始人，Chua是风险投资公司Vynn capital的创始人，Lim是欧洲信贷投资银行的首席执行官和执行董事。

Low and Wong are executives at growth equity investment firm AEI Capital Group where Low serves as deputy president of corporate development and portfolio management and Wong is senior VP of group operations and business development.

。

The OpGen board of directors deemed Bonte, Chua, and Lim as independent under applicable US Securities and Exchange Commission and Nasdaq standards and appointed them to the audit committee and compensation committee. Lim will serve as chair of the former and Chua will serve as chair of the latter.

OpGen董事会认为Bonte、Chua和Lim根据适用的美国证券交易委员会和纳斯达克标准是独立的，并任命他们为审计委员会和薪酬委员会成员。林将担任前者的主席，蔡将担任后者的主席。

Solvd Health: Mark Hazeltine, Ron McCullough

Solvd Health, a Carlsbad, Califorinia-based pharmacogenomic testing and health information company, has appointed Mark Hazeltine as CFO and Ron McCullough as VP of clinical operations.

Solvd Health是一家总部位于加利福尼亚州卡尔斯巴德的药物基因组学测试和健康信息公司，已任命Mark Hazeltine为首席财务官，Ron McCullough为临床运营副总裁。

Hazeltine previously served as chief business officer at Exagen, where he also previously held roles including senior VP of finance and corporate development, general manager, and chief operating officer. He holds a bachelor's degree in business administration from the University of San Diego and an MBA from the University of Southern California..

Hazeltine曾担任Exagen的首席商务官，此前他还担任过财务和公司发展高级副总裁、总经理和首席运营官。他拥有圣地亚哥大学工商管理学士学位和南加州大学工商管理硕士学位。。

McCullough previously served as CSO and cofounder of Intrigue Health. He also chaired the strategic advisory board at Claire Health and was senior VP of operations at Pathnostics. He holds a PhD in molecular and cellular biology and biochemistry from Boston University, an MBA from the University of San Diego, and a BS in chemistry and biochemistry from the University of Arizona..

McCullough曾担任CSO和阴谋健康的联合创始人。他还担任Claire Health的战略咨询委员会主席，并担任Pathnostics的高级运营副总裁。他拥有波士顿大学分子与细胞生物学和生物化学博士学位、圣地亚哥大学MBA学位和亚利桑那大学化学与生物化学学士学位。。

Mindera Health: Kamal Adawi

Mindera Health：Kamal Adawi

Skin analytic company Mindera Health has appointed Kamal Adawi as its CFO. Adawi was previously CFO at Exagen and Pathway Genomics and has served as a director of financial planning and analysis at Exagen and GenMark Diagnostics.

皮肤分析公司Mindera Health已任命Kamal Adawi为其首席财务官。Adawi曾任Exagen和Pathway Genomics的首席财务官，并曾担任Exagen和GenMark Diagnostics的财务规划和分析总监。

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.

有关组学和分子诊断学领域高管任命、晋升和离职的其他最新信息，请参阅我们网站新闻页面上的人物。